Cocaine Topical Solution

11 November 2009

Products Affected - Description

Cocaine topical solution, 100 mg/mL, Roxane
4 mL vial (NDC 00054-8164-02) - discontinued
10 mL vial (NDC 00054-3155-40) - discontinued

Cocaine topical solution, 40 mg/mL, Roxane
4 mL vial (NDC 00054-8163-02) - discontinued
10 mL vial (NDC 00054-3154-40) - discontinued

Reason for the Shortage

Roxane states the 4% cocaine topical solution has been discontinued and could not provide a reason. The company discontinued the 10% solution in October, 2007.

Estimated Resupply Dates

• Roxane has discontinued both the 40 mg/mL, 4 mL vials and 10 mL vials. 
• Lannett has available cocaine topical solution 100 mg/mL in 4 mL vials (NDC 00527-1729-74) and 10 mL vials (NDC 00527-1729-73). The 40 mg/mL 4 mL vials and 10 mL vials are on back order and the company cannot estimate a release date.
  

Related Shortages

• Levobupivacaine Injection— No Longer Available
• Procaine Injection— No Longer Available
• Ropivacaine Injection— Resolved
• Tetracaine

Updated

November 11, 2009; October 2, 2009; August 28, 2009; August 7, 2009; November 25, 2008; October 20, 2008; September 22, 2008; August 19, 2008; July 21, 2008; July 1, 2008; June 2, 2008; April 24, 2008; copyright 2008, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins